Wegovy Injection Pen – 1 mg x 4 Doses (Semaglutide)

Wegovy Injection Pen contains semaglutide, a medication that mimics the naturally occurring hormone GLP-1 (glucagon-like peptide-1), which regulates appetite and glucose metabolism. By activating GLP-1 receptors in the brain, semaglutide helps decrease hunger, increase satiety, and slow the rate at which food leaves the stomach.

The 1 mg dose is a mid-level step in the treatment schedule, introduced after the initial 0.25 mg and 0.5 mg phases to gradually increase treatment intensity. This stepwise approach allows patients to adapt to the medication while achieving greater appetite suppression and metabolic benefits.

Each pen is pre-filled for once-weekly subcutaneous injection, providing an easy-to-use solution for home administration.

Supports appetite regulation
Semaglutide helps reduce hunger and promote a feeling of fullness after meals.

Facilitates sustainable weight management
By helping control calorie intake, the medication may contribute to gradual, consistent weight loss.

Stepwise dose progression
The 1 mg dose represents the next phase after lower starting doses, allowing a gradual adaptation.

Convenient weekly dosing
The pre-filled pen is designed for simple once-weekly injection.

Supports metabolic health
Improved appetite control and glucose metabolism may contribute to better long-term metabolic outcomes.

Wegovy (Semaglutide) Injection Pen – 1 mg is administered as a subcutaneous injection once per week.

General usage guidelines:

• Inject once weekly on the same day each week.

• The injection may be administered with or without meals.

• Recommended injection sites include the abdomen, thigh, or upper arm.

• Rotate injection sites to reduce skin irritation.

• Follow the dosing schedule recommended by your healthcare provider.

The 1 mg dose is typically used after the 0.25 mg and 0.5 mg initial phases, as part of the stepwise dose escalation recommended in the Wegovy treatment program.

For best results, treatment should be combined with healthy diet, portion control, and regular physical activity.

Wegovy (Semaglutide) should only be used under the supervision of a healthcare professional.

Important precautions:

• Common side effects may include nausea, vomiting, diarrhea, constipation, or decreased appetite.

• Inform your healthcare provider about existing medical conditions or medications before starting treatment.

• Individuals with a personal or family history of thyroid disorders should consult a doctor prior to using semaglutide.

• Do not use if allergic to semaglutide or any components of the formulation.

• Store the injection pen according to manufacturer instructions, typically refrigerated until use.

If severe side effects or allergic reactions occur, discontinue use and seek immediate medical attention.